The Story Of Our Firm | En Español
 Home    Lawyers   Litigation   Choose Us   Settlements   Search

Previous Investigations Other Litigations Bextra Research Center News & Warnings

Letter To Clients

in this section: FDA Press Release | FDA Health Advisory | Pfizer Response | FDA Report Dec '04 | Public Citizen Petition | World's Reaction | Stevens-Johnson Syndrome | FDA Talk Papers | FDA Q&A Dec 04 | Arthritis Society PR | Chelsea Therapeutics | Our Press Release | Letter To Clients


Bookmark This Page Print This Page Email This Page

Letter to our clients about the Bextra recall and Celebrex black box warning

To our clients, past, present, and future,

The pain relieving drug Bextra, manufactured by Pfizer Pharmaceuticals, was pulled from the market on April 7, 2005, after the FDA determined Bextra posed too high a risk of adverse cardiovascular events, as well as potentially fatal skin reactions such as Stevens Johnson Syndrome. Bextra also failed to demonstrate an advantage over other NSAID drugs available on the market.

Weitz & Luxenberg has already been retained by thousands of individuals who have been similarly injured as a result of Vioxx, another recalled NSAID. Additionally, over the past six months our attorneys and support staff have been accepting and investigating individual cases involving injuries caused by Bextra. If you have taken Bextra (20mg or more/day) and have suffered a heart attack, stroke, or other serious cardiovascular problem, or if you have developed a severe skin reaction or Stevens Johnson syndrome, you should contact Weitz & Luxenberg immediately to discuss your legal options.

Clients should also be aware that another NSAID, Celebrex (also made by Pfizer) was required to carry the FDA's most serious warning, a black box, on April 7, 2005. The black box warning alerts patients to the increased risk of cardiovascular and gastrointestinal dangers while taking Celebrex. Celebrex has been linked to strokes, heart attacks, and potentially life-threatening GI bleeding. Weitz & Luxenberg is currently investigating injuries caused by Celebrex use (400mg or more daily).

If you are currently taking Bextra or Celebrex, consult with your doctor about the risks and benefits associated with these drugs. If you have been injured by taking Bextra or Celebrex, fill out our Bextra or Celebrex forms, go to our FREE Bextra and Celebrex case evaluators and get your claim reviewed at no cost to you. You can contact our client relations department directly, and examine Weitz & Luxenberg's extensive Bextra and Celebrex research resources to get more information on these dangerous drugs.

If you've been hurt by Bextra or Celebrex, Weitz & Luxenberg will help you know your rights and get the compensation you deserve.

Sincerely,

Weitz & Luxenberg is no longer accepting Bextra cases.


see also:

Arthritis Society PR Arthitis Society Press Release - Bextra Recall Lawyers
Bextra Recall - Arthritis Society Press Release: Celebrex restrictions

Public Citizen Petition Bextra Lawyer - Public Citizen Bextra Recall Petition
Bextra Lawyer - Bextra recall petition from Public Citizen to the FDA.

About the Bextra Recall Bextra lawyers - about the FDA Bextra recall
Bextra Withdrawal: Letter to clients about the FDA Bextra recall

Free Legal Review:
Name:
Phone:
Email:
Case Description:



For legal help anywhere in the U.S.
Ask a Free Question:
Were you injured?

check for your response [login]
$53 million verdict — brake mechanic suffering from mesothelioma

$13.5 million verdict — one of the very first Vioxx trial cases

$15 million settlement — man wound up a paraplegic due to negligent hospital care

$37 million verdict — 2 asbestos lung cancer plaintiffs

$47 million verdict — boilermaker who died from mesothelioma

$2.6 million settlement — ill-fitting prosthesis caused decubitus ulcers

$75 million verdict — historic consolidated trial involving men who had worked at the Brooklyn Navy Yard in the 1940s and 1950s

$12.7 million verdict — iron worker who was injured due to unsafe working conditions

$8 million settlement — obstetrical malpractice resulted in neurological deficits

$64.65 million award — 4 asbestos plaintiffs

$17.5 million — consolidated trial of 5 mesothelioma victims